Glioblastoma, Part II: Molecular Targets and Clinical Trials, An Issue of Neurosurgery Clinics of North America (Volume 32-2) (The Clinics: Surgery, Volume 32-2)

The field of medicine has always been an ever-evolving one, with new discoveries and advancements being made each day. One of the areas that have seen significant progress in recent years is Neurosurgery. In particular, Glioblastoma is a form of brain cancer that has been the focus of extensive research. This deadly disease affects nearly 12,000 people in the United States each year.

In an effort to provide the latest update on the molecular and clinical trials, Elsevier has released a new issue of Neurosurgery Clinics guest-edited by Dr. Linda M. Liau, who is a renowned expert in the field. This issue provides a comprehensive look at the latest findings in Glioblastoma research, including insights into pathophysiology, molecular markers, genetic diversity, and potential therapeutic options.

The issue covers several topics, including the Pediatric Gliomas: Molecular Landscape and Emerging Targets, Novel Radiation Sensitizers, Immunotherapy Checkpoint Inhibitors, Brain Tumor Vaccines, CAR T Cells, Oncolytic Virotherapy, Targeting Cancer Stem Cells, Therapeutic Delivery to CNS, Theranostics: Dual Modality PET Tracers, and Neuroimaging and Novel Response Assessments. The book’s content is genuinely intriguing, and the fact that it is up-to-date makes it all the more appealing to medical professionals and researchers.

Under Dr. Liau’s editorship, the issue dives deep into the latest molecular and clinical trials aimed at understanding the disease and improving diagnosis and treatment. This issue provides an academic look at Glioblastoma, providing insights and knowledge that are critical for oncologists, neurologists, neurosurgeons, and other medical professionals.

The issue is made up of 240 pages and is available in digital e-book format. It is published by Elsevier and was released on May 3, 2021. The language used in the publication is English. Furthermore, the ISBN-10 is 0323813054, and the ISBN-13 is 978-0323813051.

In conclusion, if you are a medical professional, researcher, or someone interested in the intricacies of glioblastoma, this issue of Neurosurgery Clinics is a must-read. The information within provides you with an in-depth understanding of molecular and clinical trials conducted on Glioblastoma. It gives insights into the most recent research and its potential to improve the diagnosis and treatment of this deadly disease. I highly recommend ordering a copy of this issue of Neurosurgery Clinics and immersing yourself in the cutting-edge research regarding Glioblastoma.

Product Details

• Publisher ‏ : ‎ Elsevier (May 3, 2021)
• Language ‏ : ‎ English
• Hardcover ‏ : ‎ 240 pages
• ISBN-10 ‏ : ‎ 0323813054
• ISBN-13 ‏ : ‎ 978-0323813051